Skip to main content
Choices in GCA
There are a number of diseases where new biologic and targeted synthetic therapeutic options are coming online, and the temptation will be to consider them all equally. GCA is one of those diseases.
Summary of #EULAR2024 #ClinicalPearls

JAKi have expanding disease data
✅ #GCA w #UPA
✅ Awaiting data in #SLE w #UPA

Janet Pope Janetbirdope

2 years 3 months ago
Summary of #EULAR2024 #ClinicalPearls JAKi have expanding disease data ✅ #GCA w #UPA ✅ Awaiting data in #SLE w #UPA & #Deucravacitinib ✅Use in #JIA ✅No new safety signals @rheumnow @eular_org
It is almost four years since EULAR published its definition of difficult-to-treat (D2T) rheumatoid arthritis (RA) (1). This marked a formal recognition of the group of patients who, despite the advances in pharmacological therapy for RA, remain symptomatic.
Imaging in Axial Spondyloarthritis
Axial & Psoriatic Disease
EULAR 2024: New drugs for RA?

Abiprubart is an Abatacept distant relative, targeting T cell activation through a differ

Dr. John Cush RheumNow

2 years 3 months ago
EULAR 2024: New drugs for RA? Abiprubart is an Abatacept distant relative, targeting T cell activation through a different target/molecular interaction (CD40/CD154). https://t.co/3wAGjfCdcN https://t.co/2YK2OeIVZK
RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb & UCB.

Dr. John Cush RheumNow

2 years 3 months ago
RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb & UCB. All content is chosen by RheumNow & its faculty.
EULAR Daily Recap: Day 3
RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. Al

Dr. John Cush RheumNow

2 years 3 months ago
RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty.
How many #autoantibodies
Does one need in
#rheumatoid #arthritis

Need 4 citrullinated peptides
Covers off
97% of IgG

Janet Pope Janetbirdope

2 years 3 months ago
How many #autoantibodies Does one need in #rheumatoid #arthritis Need 4 citrullinated peptides Covers off 97% of IgG CVP2 ACPAs #EULAR2024 @RheumNow @eular_org https://t.co/LNFGuFXGrC
Once in remission with
#rituximab in #GPA
How long to resize
500 mg q6 mo for
4 years?
?longer
?less
#EULAR2024 @eular

Janet Pope Janetbirdope

2 years 3 months ago
Once in remission with #rituximab in #GPA How long to resize 500 mg q6 mo for 4 years? ?longer ?less #EULAR2024 @eular_org @RheumNow https://t.co/G4kU3v81je
Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find a

Peter Nash drpnash

2 years 3 months ago
Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find any pathology outside of joints, remote SpAologists, no longer physicians - easy to train rheumatology nurses to do our jobs @RheumNow #EULAR2024
EULAR 2024 Highlights: Saturday’s Recap with RheumNow https://t.co/BlOsbr9lYB

Dr. John Cush RheumNow

2 years 4 months ago
EULAR 2024 Highlights: Saturday’s Recap with RheumNow https://t.co/BlOsbr9lYB
×